Nuvation Bio Inc. Increase (Decrease) in Security Deposits
Nuvation Bio Inc. (NUVB) reported Increase (Decrease) in Security Deposits of -$4.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2025-03-06
- Nuvation Bio Inc. increase (decrease) in security deposits for the quarter ending 2023-12-31 was -$3.00K.
- Nuvation Bio Inc. increase (decrease) in security deposits for the quarter ending 2023-09-30 was $0.00.
- Nuvation Bio Inc. increase (decrease) in security deposits for the quarter ending 2022-12-31 was $0.00.
- Nuvation Bio Inc. increase (decrease) in security deposits for the quarter ending 2022-09-30 was $0.00.
- Nuvation Bio Inc. increase (decrease) in security deposits for fiscal 2024 was -$4.00K.
- Nuvation Bio Inc. increase (decrease) in security deposits for fiscal 2023 was -$3.00K, a 101.06% decline from fiscal 2022.
- Nuvation Bio Inc. increase (decrease) in security deposits for fiscal 2022 was $283.00K.
- Nuvation Bio Inc. increase (decrease) in security deposits for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Security Deposits 3 month | Increase (Decrease) in Security Deposits 6 month | Increase (Decrease) in Security Deposits 9 month | Increase (Decrease) in Security Deposits 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$4.00K 10-K · filed 2025-03-06 | |||
| 2023-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$3.00K derived: sum of 2 quarters · filed 2025-03-06 | -$3.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $283.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $283.00K 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $283.00K 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |